| Current Price | $9.07 | Mkt Cap | $0.00 |
|---|---|---|---|
| Open | $8.94 | P/E Ratio | 0.00 |
| Prev. Close | $9.07 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $8.86 - $9.35 | Volume | 6,035,755 |
| 52-Wk Range | $8.86 - $9.35 | Avg. Daily Vol. |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $9.07 | Mkt Cap | $0.00 |
|---|---|---|---|
| Open | $8.94 | P/E Ratio | 0.00 |
| Prev. Close | $9.07 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $8.86 - $9.35 | Volume | 6,035,755 |
| 52-Wk Range | $8.86 - $9.35 | Avg. Daily Vol. |
The best Bull and Bear pitches based on recency and number of recommendations.
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
PensionExtender
(52.38)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
+62.72
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(76.18)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
+81.97
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Recs
FVelociraptor
(96.72)
Submitted: 11/13/2019 6:03:19 PM :
Start Price:
$1.61
NASDAQ:BCRX Score:
-440.42
https://velociraptor.cc
Find the members with the highest scoring picks in BCRX.
Chemnerd (42.17) Score: +564.96
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cozynite | 38.51 | 3/14/2013 |
|
5Y | $1.31 | +591.98% | +141.59% | +450.39 | 0 Comment | |
| MrTwo94 | 89.47 | 11/8/2012 |
|
1Y | $1.37 | +561.68% | +171.01% | +390.67 | 0 Comment | |
| jgrnot | < 20 | 12/4/2012 |
|
5Y | $1.41 | +542.95% | +167.90% | +375.05 | 0 Comment | |
| Sytes | < 20 | 5/29/2013 |
|
3Y | $1.60 | +466.56% | +128.90% | +337.66 | 1 Comment | |
| bearonwallstreet | 65.00 | 5/16/2013 |
|
5Y | $1.70 | +433.24% | +128.41% | +304.83 | 0 Comment | |
| KeepYourCoolFool | 97.31 | 7/29/2009 |
|
5Y | $10.58 | -14.32% | +289.96% | +304.28 | 0 Comment | |
| BASSTRAX | 59.51 | 8/31/2009 |
|
1Y | $12.99 | -30.22% | +273.05% | +303.26 | 0 Comment | |
| DRASH5 | 62.88 | 7/29/2009 |
|
3W | $10.28 | -11.82% | +291.16% | +302.98 | 0 Comment | |
| WeathermanGR13 | 94.79 | 8/17/2009 |
|
5Y | $9.88 | -8.25% | +284.90% | +293.14 | 0 Comment | |
| warrenout3 | 44.83 | 12/3/2012 |
|
5Y | $1.63 | +456.13% | +165.16% | +290.97 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
